Zusammenfassung
Klinische Symptome sind unverändert Hauptgründe, an eine CF zu denken. Auch wenn sich die Möglichkeiten der Diagnostik in den letzten Jahrzehnten verbessert haben, wird die CF bei vielen Kindern immer noch nicht rechtzeitig erkannt. Dies liegt vor allem daran, dass Symptome nicht als hinweisend auf die Erkrankung angesehen und die entsprechenden diagnostischen Testverfahren, wie die Bestimmung der Natrium- und Chloridkonzentration im Schweiß, nicht eingesetzt werden. In Abwesenheit eines sicheren und flächendeckenden Neugeborenenscreenings sind es die klinischen Zeichen, die den betreuenden Arzt an die Erkrankung denken lassen müssen und zur Einleitung der weiteren Diagnostik führen sollten. Für die verschiedenen Organsysteme sei vor allem auch auf die detaillierten Darstellungen im Teil Organspezifische Aspekte verwiesen
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Liteatur zu 5.1
Abernathy R (1976) Bulging fontanelle as presenting sign in cystic fibrosis. Am J Dis Child 130:1360–1362
Avolio L, Parigi G, Grasso M, Fasani R, Verga G (1997) Fortuitous diagnosis of cystic fibrosis at laparotomy for acute appendicitis. Pediatr Surg Int 12:441–442
Beckerman R, Taussig LM (1979) Hypoelectrolytemia and metabolic alkalosis in infants with cystic fibrosis. Pediatrics 63:580–583
Chillon M, Casals T, Mercier (1995) Mutations in the cystic fibrosis gene in patients with congenital absence of the vas deference. N Engl J Med 332:1475–1480
Cystic Fibrosis Foundation Patient Registry 1998, Annual Data Report (1999) Bethesda, MD, Sept 1999
Davis PB, Drumm M, Konstan M (1996) Cystic fibrosis. Am J Respir Crit Care Med 154:1229–1256
Dehner L, Scott D, Stocker J (1986) Meconium Peritonitis: a clinicopathologic study of four cases with a review of the literature. Hum Pathol 17:807–812
Dolan TJ (1976) Hemolytic anemia and edema as the initial sign in infants with cystic fibrosis. Clin Pediatr 15:597–600
European Registry for Cystic Fibrosis: Report 1997
Farrell PM, Kosorok MR, Lakova A, Shen MS et al. (1997) Nutritional benefits of neonatal Screening for cystic fibrosis. N Engl J Med 337:963–969
FitzSimmons SC (1993) The changing epidemiology of cystic fibrosis. J Pediatr 122:1–9
Fuchs JR, Langer JC (1998) Long-term outcome after neonatal meconium obstruction. Pediatrics 101:7–12
Gaskin K, Gurwitz D, Durie P, Corey M, Levison H, Forstner G (1982) Improved respiratory prognosis in patients with cystic fibrosis with normal fat absorption. J Pediatr 100:857–862
Ghali F, Steinberg J, Tunnessen W (1996) Picture of the month. Arch Pediatr Adolesc Med 150:99–100
Giglio L, Canduso M, Orazio CD, Mastella G, Faraguna D (1997) Failure to thrive: The earliest feature of cystic fibrosis in infants diagnosed by neonatal Screening. Acta Paediatr 86:1162–1165
Goshen R, Kerem E, Shoshani T, Feigin E, Yahav Y (1992) Cystic fibrosis manifested as undescended testis and absence of vas deferens. Pediatrics 90:982–983
Gunn T, Belmonte M, Colle E, Dupont C (1978) Edema as the presenting Symptom of cystic fibrosis. Am J Dis Child 132:317–338
Hamosh A, Corey M, for the cystic fibrosis genotype-phenotype consortium (1993) Correlation between genotype and phenotype in patients with cystic fibrosis. N Engl J Med 329:1308–1313
Hirthler M, Goldthorn J (1991) Neonatal presentation of cystic fibrosis requiring ECMO. J Pediatr Surg 26:94–95
Holsclaw D, Rocmans C, Shwachman H (1971) Intussusception in patients with cystic fibrosis. Pediatrics 48: 51–58
Katznelson D, Szeinberg A, Augarten A, Yahav Y (1997) The critical first six months in cystic fibrosis: a Syndrome of severe bronchiolitis. Ped Pulmonol 24:134–136
Kennedy J, Dinwiddie R, Daman-Willems C, Dillon M, Matthew D (1990) Pseudo-Bartter’s Syndrome in cystic fibrosis. Arch Dis Child 65:786–787
Lamy S, da-Silva L, Lopes B, Pacheco P, Lavinha J, Amaral J, Marques J (1997) Mucoviscidosis with respiratory symptomatology in the neonatal period. Acta Med Port 10:209–212
Lee P, Roloff D, Howatt W (1974) Hypoproteinemia and anemia in infants with cystic fibrosis. JAMA 228:585–588
Littlewood J (1992) Gastrointestinal complications. Br Med Bull 48:847–859
Lloyd-Still J, Khaw K, Shwachman H (1974) Severe respiratory disease in infants with cystic fibrosis. Pediatrics 53: 678–682
Lykavieris P, Bernard O, Hadchouel M (1994) Neonatal cholestasis as the presenting feature in cystic fibrosis. Arch Dis Child 75:67–70
Petersen R, Petersen V, Robb R (1968) Vitamin A deficiency with xerophthalmia and night blindness in cystic fibrosis. Am J Dis Child 116:662–665
Qualitätssicherung Mukoviszidose 1997, Zentrum für Qualitätsmanagement im Gesundheitswesen, Hannover
Rosenbluth D, Goodenberger D (1997) Cystic fibrosis in an elderly woman. Chest 112:1124–1126
Rosenstein BJ (1998) Making and confirming the diagnosis. In: Orenstein D, Stern R (eds) Treatment of the hospitalized cystic fibrosis patient. Marcel Dekker, New York, pp 1–42
Rosenstein BJ, Cutting G (1998b) The diagnosis of cystic fibrosis: a consensus Statement. J Pediatr 132:589–595
Sardet A, Couvreur J, Costil J, Just J, Boule M, Tournier G (1990) Mucoviscidose du mourrisson révélée par une détresse respiratoire grave. Arch Fr Pediatr 47:653–656
Shalon LB, Adelson JW (1996) Cystic fibrosis. Gastrointestinal complications and gene therapy. Pediatr Clin North Am 43:157–194
Stern R, Boat TF, Doershuk C, Tucker A, Miller R, Matthews L (1977) Cystic fibrosis diagnosed after age 13. Ann Intern Med 87:188–191
Sturgess J, Imrie J (1982) Quantitative evaluation of the development of tracheal submucosal glands in infants with cystic fibrosis. Am J Pathol 106:303–311
Taylor WF, Qaqundah BY (1972) Neonatal jaundice associated with cystic fibrosis. Am J Dis Child 123:161–162
Torstenson O, Humphrey G, Edson J, Warwick W (1970) Cystic fibrosis presenting with severe hemorrhage due to vitamin K malabsorption: a report of three cases. Pediatrics 45:857–860
Tunkel D, Naclario R, Baroody F, Rosenstein B (1994) Bilateral maxillary sinus mucoceles in an infant with cystic fibrosis. Otolaryngol Head Neck Surg 111:116–120
Wilfond B, Farrel P, Laxova A, Mischler E (1994) Severe hemolytic anemia associated with vitamin E deficiency in infants with cystic fibrosis. Clin Pediatr 33:2–7
Liteatur zu 5.2
Ao A, Ray P, Harper J et al. (1996) Clinical experience with preimplantation genetic diagnosis of cystic fibrosis (F508). Prenat Diagn 16:137
Corteville JE, Gray DL, Langer JC (1996) Bowel abnormalities in the fetus—correlation of prenatal ultrasonographic findings with outcome. Am J Obstet Gynecol 175: 724
Friderici KH (1997) Molecular diagnostics for cystic fibrosis. Clin Lab Med 17:59–72
Rosenstein BJ (1998) What is a cystic fibrosis diagnosis? Clin Chest Med 19:423–441
Liteatur zu 5.3
Brock DJ (1995) Heterozygote Screening for cystic fibrosis. Eur J Hum Genet 3:2–13 (Review)
Brock DJH (1996) Prenatal Screening for cystic fibrosis—5 year’s experience reviewed. Lancet 347:148–150
Burn J, Magnay D (1994) Screening for cystic fibrosis. Screening in primary care is preferable. BMJ 309:878
Callahan NP, Bloom D, Sorensen JR, de Villis BM, Cheuvront B (1995) CF carrier testing: experience of relatives. J Genet Counsel 4:83–95
Clausen GH, Brandt NJ, Schartz M, Skovby F (1996) Psychological and social impact of carrier Screening for cystic fibrosis among pregnant women — a pilot study. Clin Genet 49:200–205
Clayton EW, Hannig VL, Pfotenhauer JP, Parker RA, Campbell PW, Phillips JA (1995) Teaching about cystic fibrosis carrier Screening by using written and video Information. Am J Hum Genet 57:171–181
Conference Statement on genetic testing for cystic fibrosis (1999) Genetic testing for cystic fibrosis. National Institutes of Health Consensus Development. Arch Intern Med 159:1529–1539
Conway SP, Allenby K, Pond MN (1994) Patient and parental attides toward genetic Screening and its implications at an adult cystic fibrosis centre. Clin Genet 45:308–312
Cuckle HS, Quirke P, Sehmi I, Lewis F, Murray J, Cross D et al. (1996) Antenatal Screening for cystic fibrosis. Br J Obstet Gynaecol 103:795–799
Cunningham S, Marshall P (1998) Influence of five years of antenatal Screening on the pediatric cystic fibrosis population in one region. Arch Dis Child 78:345–348
Denayer L, Welkenhuysen M, Evers-Kiebooms G, Cassiman JJ, Van den Berghe H (1997) Risk pereeption after CF carrier testing and impact of the test result on reproductive decision making. Am J Med Genet 14:422–428
Evers-Kiebooms G, Denayer L, Cassiman JJ, van den Berghe H (1988) Family planning decisions after the birth of a cystic fibrosis child. The impact of prenatal diagnosis. Scand J Gastroenterol Suppl 143:38–46
Evers-Kiebooms G (1995) Risk communication in genetic counselling and genetic risk pereeption. Eur Rev Appl Psychol 45:23–27
Fanos JH, Johnson JP (1995) Barriers to carrier testing for adult cystic fibrosis sibs: the importance of not knowing. Am J Med Genet 59:85–91
Gervais RM, Lafitte JJ, Dumur V, Kesteloot M, Lalau G, Houdret N et al. (1993) Sweat chloride and F508 mutation in chronic bronchitis of bronchieetasis. Lancet 342:997
Grody WW, Dunkel-Schetter C, Tatsugawa ZH, Fox MA, Fung CY, Cantor RM et al. (1997) PCR-based Screening for cystic fibrosis carrier mutations in an ethnically diverse pregnant population. Am J Hum Genet 60:935–947
Haddow JE, Bradley LA, Palomaki GE, Doherty RA (1999) Issues in implementing prenatal Screening for cystic fibrosis: results of a working Conference. J Med Screen 6:60–66
Holloway, S, Brock DJH (1994) Cascade testing for the identification of carriers of cystic fibrosis. J Med Screen 1: 159–164
Jung U, Urner U, Grade K, Coutelle C (1994) Acceptability of carrier Screening for cystic fibrosis during pregnancy in a German population. Hum Genet 94:19–24
Livingstone J, Axton RA, Gifillan A, Mennia M, Compton M, Liston WA et al. (1994) Antenatal Screening for cystic fibrosis: a trial of the couple model. BMJ 308: 1459–1462
Mennie ME, Gilfillan A, Compton M, Curtis L, Liston WA, Pullen I et al. (1992) Prenatal Screening for cystic fibrosis. Lancet 340:214–216
Mennie ME, Axworthy D, Liston WA, Brock DJ (1997) Prenatal Screening for cystic fibrosis carriers: does the method of testing affect the longer-term understanding and reproductive behaviour of women? Prenat Diagn 17: 853–860
Mennuti MT, Thomson E, Press N (1999) Screening for cystic fibrosis carrier State. Obstet Gynecol 93:456–461
Miedzybrodzka ZH, Hall MH, Mollison J, Tempeton A, Russel IT, Dean JGS et al. (1995) Antenatal Screening for carriers of cystic fibrosis: randomised trial of stepwise vs couple Screening. BMJ 310:353–357
Mischler EH, Wilfond BS, Fost N, laxova A, Reiser C, Sauer CM et al. (1998) Cystic fibrosis newborn Screening: impact on reproduetive behaviour and implications for genetic counselling. Pediatrics 102:44–52
Murray J, Cuckle H, Taylor G, Littlewood J, Hewison J (1999) Screening for cystic fibrosis. Health Technol Assess 3:(8) 1–101
Payne Y, Williams M, Cheadle J, Stott NCH, Rowlands M, Schickle D et al. (1997) Carrier Screening for cystic fibrosis in primary care: evaluation of a project in South Wales. Clin Genet 51:153–163
Pignatti PF, Bombieri C, Marigo C, Benetazzo M, Luisetti M (1995) Increased incidence of cystic fibrosis gene mutations in adults with disseminated bronchietasis. Hum Mol Genet 4:635–639
Positionspapier (1996) Kommission für Offentlichkeitsarbeit und ethische Fragen der Gesellschaft für Humangenetik e.V. Med Genetik 8:125–131
Sorensen JR, Cheuvront B, DeVellis B, Callandan N, Silverman L, Koch G (1997) Acceptance of home and clinic based cystic fibrosis carrier education and testing by first second and third degree relatives of cystic fibrosis patients. Am J Med Genet 70:121–129
Super M, Schwarz MJ, Malone G, Roberts T, Haworth A, Dermody G. (1994) Active cascade Screening for carriers of cystic fibrosis gene. BMJ 308:1462–1468
Tambor ES, Bernhardt BA, Chase G, Faden RR, Geller G, Hofmann KJ et al. (1994) Offering cystic fibrosis carrier Screening to an HMO population: factors associated with utilization. Am J Hum Genet 55:626–637
Ten Kate LP (1990) Carrier Screening for cystic fibrosis and other autosomal recessive diseases. Am J Hum Genet 47: 359–361
Turner G, Meagher W, Willis C, Colley P (1993) Cascade Screening for carrier Status in cystic fibrosis in a large family. Med J Aust 159:163–165
Waitrik BJ, Myer CM, Cotton RT (1993) Cystic fibrosis presenting with sinus disease in children. Am J Dis Child 147: 258
Wald NJ, Brock DJ, Haddow JE, Doherty RA (1995) Antenatal Screening for cystic fibrosis. BMJ 310:1199
Watson EK, Mayall E, Chapple J, Dalziel M, Harrington K, Williams C et al. (1991a) Screening for carriers of cystic fibrosis through primary health care Services. BMJ 303: 504–507
Watson EK, Williamson R, Chapple J (1991b) Attidues to carrier Screening for cystic fibrosis: a survey of health care Professionals, relatives of sufferers and other members of the public. Br J Gen Pract 41:237-240
Wertz DG, Janes SR, Rosenfield JM, Erbe RW (1992) Attitudes toward the prenatal diagnosis of cystic fibrosis: factors in decision making among affected families. Am J Hum Genet 50:1077–1085
Witt DR et al. (1996) Cystic fibrosis heterozygote Screening in 5161 pregnant women. Am J Hum Genet 58:823–835
Liteatur zu 5.4
Al Jader LN, Goodchild MC, Ryley HC et al. (1990) Attitudes of parents of cystic fibrosis children towards neonatal Screening and antenatal diagnosis. Clin Genet 38:460–465
Armstrong DS, Grimwood K, Carlin JB et al. (1997) Lower Airway Inflammation in Infants and young Children with Cystic Fibrosis. Am J Respir Crit Care Med 156:1197–1204
Baroni MA, Anderson YE,Mischler E (1997) Cystic fibrosis newborn Screening: impact of early Screening results on parenting stress. Pediatr Nursing 23:143–151
Bronstein MN, Sokol RJ, Abman SH et al. (1992) Pancreatic insufficiency, growth, and nutrition in infants identified by newborn Screening as having cystic fibrosis. J Pediatr 120: 533–540
Castellani C, Bonizzato A, Mastella G (1997) CFTR mutations and IVS8-5T variant in newborns with hypertrypsinaemia and normal sweat test. J Med Genet 34:297–301
Crossley JP, Eliott RP, Smith PA (1979) Dried blood spot Screening for cystic fibrosis in the newborn. Lancet i: 472–474
Cystic Fibrosis Foundation. Report of the patient registry 1979
Cystic Fibrosis Foundation, Patient Registry 1995, Annual Data Report, Bethesda, Maryland, August 1996
Cystic Fibrosis Foundation, Patient Registry 1996, Annual Data Report, Bethesda, Maryland, August 1997
Dankert-Roelse JE, TeMeerman GJ, Knol K et al. (1987) Effect of Screening for cystic fibrosis on the influence of genetic counselling. Clin Genet 32:271–275
Dankert-Roelse JE, TeMeerman GJ (1995) Long-term prognosis of patients with cystic fibrosis in relation to early detection by neonatal Screening and treatment in a cystic fibrosis centre. Thorax 50:712–718
Dankert-Roelse JE, te Meerman GJ (1997) Screening for cystic fibrosis. Time to change our position? N Engl J Med 337:997–998
Deufel T, Rabe H, Wieser T, Meitinger T, Rosenecker J, Bertele-Harms R, Harms K, Hadorn HB, Roscher AA (1993) Mutation analysis in the diagnosis of cystic fibrosis. Eur J Pediatr 152:909–911
Evers-Kiebooms G, Denayer L, van den Berghe H (1990) A child with cystic fibrosis II Subsequent family planning decisions, reproduction and use of prenatal diagnosis. Clin Genet 37:207–215
Farell PM, Kosorok MR, Laxova A et al. (1997a) Nutritional benefits of neonatal Screening for cystic fibrosis. N Engl J Med 337:963–969
Farell P, Shen G, Splaingard M et al. (1997b) Acquisition of Pseudomonas aeruginosa in children with cystic fibrosis. Pediatrics l00(s):E21–E29
Gregg RG, Simantel A, Farell PM et al. (1997) Newborn Screening for cystic fibrosis in Wisconsin: Comparison of biochemical and molecular methods. Pediatrics 99: 819–824
Hammond KB, Abman SH, Sokol RJ, Accurso FJ (1991) Efficacy of statewide Screening for cystic fibrosis by assay of trypsinogen concentrations. N Engl J Med 325:769–774
Jedlidka-Köhler I, Götz M, Eichler I (1994) Utilization of prenatal diagnosis for cystic fibrosis over the past seven years. Pediatrics 94:13–16
Johansen HK, Kovesi TA, Koch C et al.(1998)Pseudomonas aeruginosa and Burkholderia cepacia Infection in Cystic Fibrosis Patients treated in Toronto and Copenhagen. Pediatr Pulmonol 26:89–96
Khan TZ, Wagner JS, Bost T et al. (1995) Early pulmonary inflammation in infants with cystic fibrosis. Am J Respir Crit Care Med 151:1075–1082
Kosorok MR, Jalaluddin M, Farell PM et al. (1998) Comprehensive Analysis of Risk Factors for Acquisition of Pseudomonas aeruginosa in young children with cystic fibrosis. Pediatr Pulmonol 26:81–88
Lucotte G, Perignon JL, Lenoir G (1991) Transient neonatal hypertrypsinaemia as test for AF508 heterozygosity. Lancet 337:988
Marcus MS, Sondel SA, Farell PM et al. (1991) Nutritional Status of infants with cystic fibrosis associated with early diagnosis and Intervention. Am J Clin Nutr 54:578–580
Mischler EH, Wilfond BS, Fost N et al. (1998) Cystic fibrosis newborn Screening: impact on reproductive behavior and implications for genetic counseling. Pediatrics 102:44–52
Morison S, Dodge JA, Cole TJ et al. (1997) Height and weight in cystic fibrosis: a cross sectional study. Arch Dis Child 77:497–500
National Institutes of Health (1997) Genetic testing for cystic fibrosis. NIH consensus development Statement. Bethesda, MD
Pederzini F, Faraguna D, Giglio L et al. (1990) Development of a Screening System for cystic fibrosis: meconium or blood spot trypsin assay or both? Acta Paediatr Scand 79: 935–942
Pollitt RJ, Dalton A, Evans S et al. (1997) Neonatal Screening for cystic fibrosis in the Trent region (UK): two-stage immunoreactive trypsin Screening compared with a threestage protocol with DNA analysis as an intermediate Step. J Med Screen 4:23–28
Pollitt RJ, Green A, McCabe CJ et al. (1997b) Neonatal Screening for inborn errors of metabolism: cost, yield and outcome. Health Technol Assess 1(7)
Pollitt R (1998) Neonatal Screening for cystic fibrosis. Early diagnosis is important to parents even if it makes little difference to outcome. BMJ 317(7155):411–412
Qualitätssicherung Mukoviszidose. Überblick über den Gesundheitszustand der Patienten in Deutschland 1996, S22
Ramsey BW (1997) New clinical development: from the test tube to the bedside. Pediatr Pulmonol Suppl 14:72
Ranieri E, Ryall RG, Morris CP et al. (1991) Neonatal Screening strategy for cystic fibrosis using immunoreactive trypsinogen and direct gene analysis. BMJ 302 (6787): 1237–1240
Ranieri E, Lewis BD, Morris CP, Wilcken B (1996) Neonatal Screening using combined biochemical and DNA-based techniques. In: Dodge J (ed) Cystic fibrosis — Current topics, vol 3. John Wiley & Sons, New York, pp 181–206
Reid L (1980) Cardiopulmonary pathology. In: Sturgess J (ed) Perspectives of cystic fibrosis. Imperial Press, Toronto, pp 198–215
Rock MJ, Mischler EH, Farell PM et al. (1990) Newborn Screening for cystic fibrosis is complicated by age-related decline in immunoreactive trypsinogen levels. Pediatrics 85:1001–1007
Rosenstein BJ, Cutting GR (1998) The diagnosis of cystic fibrosis: a consensus Statement. Cystic Fibrosis Foundation Consensus Panel. J Pediatr 132:589–595
Stephan V, Busch EW, Kollberg H, Hellsing K (1975) Cystic fibrosis detection by means of a test strip. Pediatrics 55: 35–38
Tluczek A, Mischler EH, Farrell PM et al. (1992) Parents’ knowledge of neonatal Screening and response to false-positive cystic fibrosis testing. J Dev +Behav Pediatr 13: 181–186
Tümmler B, Storrs T, Dziadek V et al. (1996) Geographie distribution and origin of CFTR mutations in Germany. Hum Genet 97:727–731
Wald NJ, Morris JK (1998) Neonatal Screening for cystic fibrosis. BMJ 316:404–405
Wilcken B (1998) Neonatal Screening for Cystic Fibrosis: It is Time. Pediatr Pulmonol 26:219–221
Liteatur zu 5.5
Baker E, Jeunemaitre X, Portal AJ, Grimbert P, Markandu N, Persu A, Corvol P, MacGregor G (1998) Abnormalities of nasal potential difference measurement in Liddle’s Syndrome. J Clin Invest 102:10–14
Behm JK, Hagiwara G, Lewiston NJ, Quinton PM, Wine JJ (1987) Hyposecretion of beta-adrenergically induced sweating in cystic fibrosis heterozygotes. Pediatr Res 22: 271–276
Bronsveld I, Bijman J, Mekus F, Ballmann M, Veeze HJ, Tümmler B (1999) Clinical presentation of exclusive cystic fibrosis lung disease. Thorax 54:278–281
Cohn JA, Friedman KJ, Noone PG, Knowles MR, Silverman LM, Jowell PS (1998) Relation between mutations of the cystic fibrosis gene and idiopathic pancreatitis. N Engl J Med 339:653–658
Delmarco A, Pradal U, Cabrini G, Bonizzato A, Mastella G (1997) Nasal potential difference in cystic fibrosis patients presenting borderline sweat test. Eur Respir J 10: 1145–1149
Dohle GR, Veeze HJ, Overbeek SE, van den Ouweland AM, Halley DJ, Weber RF, Niermeijer MF (1999) The complex relationships between cystic fibrosis and congenital bilateral absence of the vas deferens: clinical, electrophysiological and genetic data. Hum Reprod 14:371–374
Fajac I, Lacronique J, Lockhart A, Dall’Ava-Santucci J, Dusser DJ (1998) Silver/silver electrodes for measurement of potential difference in human bronchi. Thorax 53:879–881
Farrell PM, Koscik RE (1996) Sweat chloride concentrations in infants homozygous or heterozygous for AF508 cystic fibrosis. Pediatrics 97:524–528
Gibson LE, Cooke RE (1959) Test for the concentration of electrolytes in cystic fibrosis of the pancreas utilizing Pilocarpine by iontophoresis. Pediatrics 24:545–549
Gowen CW, Lawson EE, Gingras-Leatherman J, Gatzy JT, Boucher RC, Knowles MR (1986) Increased nasal potential difference and amiloride sensitivity in neonates with cystic fibrosis. J Pediatr 108:517–521
Hofmann T, Bohmer O, Hüls G, Terbrack HG, Bittner P, Klingmüller V, Heerd E, Lindemann H (1997) Conventional and modified nasal potential-difference measurement in cystic fibrosis. Am J Respir Crit Care Med 155: 1908–1913
Knowles M, Gatzy J, Boucher R (1981) Increased biolelectric potential difference across respiratory epithelia in cystic fibrosis. N Engl J Med 305:1489–1495
Knowles M, Gatzy J, Boucher R (1983) Relative ion permeability of normal and cystic fibrosis nasal epithelium. J Clin Invest 71:1410–1417
Knowles MR, Paradiso AM, Boucher RC (1995) In vivo nasal potential difference: techniques and protocols for assessing efficacy of gene transfer in cystic fibrosis. Hum Gene Ther 6:445–455
LeGrys VA (1996) Sweat testing for the diagnosis of cystic fibrosis: practical considerations. J Pediatr 129:892–897
Mall M, Bleich M, Schürlein M, Kühr J, Seydewitz HH, Brandis M, Greger R, Kunzelmann K (1998) Cholinergic ion secretion in human colon requires coactivation by cAMP. Am J Physiol 275:G1274–G1281
Mekus F, Ballmann M, Bronsveld I, Dörk T, Bijman J, Tümmler B, Veeze HJ (1998) Cystic-fibrosis-like disease unrelated to the cystic fibrosis transmembrane conductance regulator. Hum Genet 102:582–586
Mickle JE, Macek M Jr, Fulmer-Smentek SB, Egan MM, Schwiebert E, Guggino W, Moss R, Cutting GR (1998) A mutation in the cystic fibrosis transmembrane conductance regulator gene associated with elevated sweat chloride concentrations in the absence of cystic fibrosis. Hum Mol Genet 7:729–735
Middleton PG, Geddes DM, Alton EW (1994) Protocols for in vivo measurement of the ion transport defects in cystic fibrosis nasal epithelium. Eur Respir J 7:2050–2056
National Committee for Clinical Laboratory Standards (1994) Sweat Testing: sample collection and quantitative analysis — approved guideline (Document C34-A). Wayne, Pennsylvania
Pradal U, Castellani C, Delmarco A, Mastella G (1998) Nasal potential difference in congenital absence of the vas deferens. Am J Respir Crit Care Med 158:896–901
Quinton PM (1986) Missing Cl conductance in cystic fibrosis. Am J Physiol 251: C649–C652
Quinton PM (1990) Cystic fibrosis: a disease in electrolyte transport. FASEB J 4:2709–2717
Quinton PM, Bijman J (1983) Higher bioelectric potentials due to decreased chloride absorption in the sweat glands of patients with cystic fibrosis. N Engl J Med 308: 1185–1189
Reddy MM, Bell CL, Quinton PM (1997) Cystic fibrosis affects specific cell type in sweat gland secretory coil. Am J Physiol 273:C426–C433
Report of the committee for a study for evaluation of testing for cystic fibrosis (1976) J Pediatr 88:711–750
Rosenstein BJ, Cutting GR (1998) The diagnosis of cystic fibrosis: a consensus Statement. Cystic Fibrosis Foundation Consensus Panel. J Pediatr 132:589–595
Sato K, Sato F (1984) Defective beta-adrenergic response of cystic fibrosis sweat glands in vivo and in vitro. J Clin Invest 73:1763–1771
Sato K, Sato F (1988) Variable reduction in beta-adrenergic sweat secretion in cystic fibrosis heterozygotes. J Lab Clin Med 111:511–518
Veeze HJ, Halley DJ, Bijman J, de Jongste JC, de Jonge HR, Sinaasappel M (1994) Determinants of mild clinical Symptoms in cystic fibrosis patients. Residual chloride secretion measured in rectal biopsies in relation to the genotype. J Clin Invest 93:461–466
Veeze HJ, Sinaasappel M, Bijman J, Bouquet J, de Jonge HR (1991) Ion transport abnormalities in rectal suction biopsies from children with cystic fibrosis. Gastroenterology 101:398–403
Liteatur zu 5.6
Aberer E, Gebhart W, Mainitz M, Pollak A, Reichel G, Scheibenreiter S (1987) Sweat glands in pseudohypoaldosteronism. Hautarzt 38:484–487
Ballauff A, Wendel U, Kupke I, Kuhnle U (1994) A partial form of pseudohypoaldosteronism type I without renal sodium wasting. J Pediatr Endocrinol 7:57–60
Bates C, Baum M, Quigley R (1997) Cystic fibrosis presenting with hypokalemia and metabolic alkalosis in a previously healthy adolescent. J Am Soc Nephrol 8:352–356
Birkrant D, Stern R (1991) Sweat testing in the 90s. Am J Asthma Allergy Pediatrician 4:194–198
Bistritzer T, Lahat E, Eshel G, Barr J, Hanukoglu A, Aladjem M (1996) Severe pseudohypoaldosteronism in a pair of twins not associated with hydramnions. Pediatr Nephrol 10:438–441
Bourke B, Goggin N, Walsh D, Kennedy S, Setchell K, Drumm B (1996) Byler-like familial cholestasis in an extended kindred. Arch Dis Child 75:223–227
Brand P, Gerritsen J, van-Aalderen W (1996) A baby with eczema and an abnormal sweat test. Lancet 348:932–932
Doherty-Fuller E, Copeland K (1988) Sweat tests in patients with diabetes insipidus. Clin Pediatr 27:330–332
Falkman C (1972) Cystic fibrosis — a psychological study of 52 children and their families. Acta Paediatr Scand Suppl 269:7–99
Foulston C, Gall G, Mitchell I, Cooper D, Scott R (1985) Transient neutral fat steatorrhea, elevated sweat chloride concentration, and hypoparathyroidism in a child with celiac disease. J Pediatr Gastroenterol Nutr 4:143–145
Goodchild M, Dodge J (1985) Cystic fibrosis. Biddles Ltd, Guildford
Hanukoglu A, Bistritzer T, Rakover Y, Mandelberg A (1994) Pseudohypoaldosteronism with increased sweat and saliva electrolyte values and frequent lower respiratory tract infections mimicking cystic fibrosis. J Pediatr 125:752–755
Kerem E, Bistritzer T, Hanukoglu A, Hofmann T, Zhou Z, Bennett W, MacLaughlin E, Barker P, Nash, M, Quittell L, Boucher R, Knowles MR (1999) Pulmonary epithelial sodium-channel dysfunction and excess airway liquid in pseudohypoaldosteronism. N Engl J Med 341:156–162
Kumar S, Lester M, Bratton D (1996) KID Syndrome associated with elevated sweat chloride. Pediatr Pulmonol 21: 192–194
Lloyd-Still J (1981) Familial cholestasis with elevated sweat electrolytes. J Pediatr 99:580–581
Lüthi M, Zurbrügg R (1983) A puzzling triad: anorexia nervosa, high sweat electrolytes and indication to partial exocrine pancreatic insufficiency. Helv Paediatr Acta 38: 149–158
Mace J, Schanberger J (1971) Elevated sweat Chlorides in a child with malnutrition. Clin Pediatr 10:285–286
Marthinsen L, Kornfalt R, Aili M, Andersson D, Westgren U, Schaedel C (1998) Recurrent Pseudomonas bronchopneumonia and other Symptoms as in cystic fibrosis in a child with type I pseudohypoaldosteronism. Acta Paediatr 87:472–474
National Committee for Clinical Laboratory Standards (1994): Sweat testing: sample collection and quantitative analysis — approved guideline (Document C34-A). Wayne, Pennsylvania
Polack F, Transue D, Belknap W, Freij B, Aughton D (1995) Transient elevation of sweat chloride concentration in a malnourished girl with the mauriac Syndrome. J Pediatr 126:261–263
Rodrigues M, Melo M, Reis F, Penna F (1994) Concentration of electrolytes in the sweat of malnourished children. Arch Dis Child 71:141–143
Rosenfeld R, Spigelblatt L, Chicoine R (1979) False positive sweat test, malnutrition. and the mauriac Syndrome. J Pediatr 94:240–242
Rubin BK, MacLeod P, Sturgess J, King M (1991) Recurrent respiratory infections in a child with fucosidosis: is the mucus too thin for effective transport. Pediatr Pulmonol 10:304–309
Ruddy R, Scanlin T (1987) Abnormal sweat electrolytes in a case of celiac disease and a case of psychosocial failure to thrive. Clin Pediatr 26:83–88
Silverman B, Lloyd-Still J, Hazinski TA, Hunt C (1985) Increased sweat chloride levels associated with Prostaglandin El infusion.J Pediatr 106:953–954
Liteatur zu 5.7
Chillon M, Dörk T, Casals T, Gimenez J, Fonknechten N, Will K, Ramos D, Nunes V, Estivill X (1995) A novel donor splice site in intron 11 of the CFTR gene created by mutation 1811 + 1.6 kb A- > G produces a new exon: high frequency in Spanish cystic fibrosis chromosomes and association with severe phenotype. Am J Hum Genet 56:623–629
Cuppens H, Buyse I, Baens M, Marynen P, Cassiman J-J (1992) Simultaneous Screening for 11 mutations in the cystic fibrosis transmembrane conductance regulator gene by multiplex amplification and reverse dot-blot. Mol Cell Probes 6:33–39
Dequeker E, Cassiman J-J (1998) Evaluation of CFTR gene mutation testing methods in 136 diagnostic laboratories: report of a large European external quality assessment. Eur J Hum Genet 6:165–175
Fanen P, Ghanem N, Vidaud M, Besmond C, Martin J, Costes B, Plassa F, Goossens M (1992) Molecular characterization of cystic fibrosis: 16 novel mutations identified by analysis of the whole cystic fibrosis transmembrane conductance regulator (CFTR) coding regions and splice site junctions. Genomics 13:770–776
Ferrie RM, Schwarz MJ, Robertson NH,Vaudin S, Super M, Malone G, Little S (1992) Development, multiplexing, and application of ARMS tests for common mutations in the CFTR gene. Am J Hum Genet 51:251–262
Grompe M (1993) The rapid detection of unknown mutations in nucleic acids. Nat Genet 5:111–117
Highsmith WE, Burch LH, Boat TE, Spock A, Gorvoy J, Quittel L, Friedman KJ (1994) A novel cystic fibrosis gene mutation is common in patients with normal sweat chloride concentrations. N Engl J Med 331:974–980
Liechti-Gallati S, Schneider V, Neeser D, Kraemer R (1999) Two-buffer PAGE System based SSCP/HD analysis: a general protocol for rapid and sensitive mutation Screening in cystic fibrosis and any other human genetic disease. Eur J HumGenet 7:590–598
Mercier B, Lissens W, Audrezet M-P, Bonduelle M, Liebaers I, Férec C (1993) Detection of more than 94% cystic fibrosis mutations in a sample of Belgian population and identification of four novel mutations. Hum Mutat 2:16–20
Morral N, Nunez V, Casals T, Estivill X (1991) CA/GT microsatellite alleles within the cystic fibrosis transmembrane conductance regulator (CFTR) gene are not generat-ed by unequal crossingover. Genomics 10:692–698
Morral N, Estivill X (1992) Multiplex PCR amplification of three microsatellites within the CFTR gene. Genomics 13: 1362–1364
Ravnik-Glavac M, Glavac D, Chemik M, Di Sant’Agnese P, Dean M (1994 a) Screening for CF mutations in adult cystic fibrosis patients with a directed and optimized SSCP strategy. Hum Mutat 3:231–238
Ravnik-Glavac M, Glavac D, Dean M (1994b) Sensitivity of single Strand conformation polymorphism and heteroduplex method for mutation detection in the cystic fibrosis gene. Hum Mol Genet 3:801–807
Romey MC, Tuffery S, Desgeorges M, Bienvenu T, Demaille J, Claustres M (1996) Transcript analysis of CFTR frameshift mutations in lymphocytes using the reverse transcription polymerase chain reaction technique and the protein truncation test. Hum Genet 3:328–332
Rommens J, Kerem B, Greer W, Chang P, Tsui LC, Ray P (1990) Rapid nonradioactive detection of the major cystic fibrosis mutation. Am J Hum Genet 46:395–396
Shuber AP, Skoletsky J, Stern R, Handelin B (1993)Efficient 12-mutation testing in the CFTR gene: a general model for complex mutation analysis. Hum Mol Genet 2:153–158
Wall J, Cai S, Chehab FF (1995) A 31-mutation assay for cystic fibrosis testing in the clinical molecular diagnostics laboratory. Hum Mutat 5:333–338
Liteatur zu 5.8
Armstrong D, Grimwood K, Carlin J, Carzino R, Gutièrrez J, Hüll J, Olinsky A, Phelan E, Robertson C, Phelan P (1997) Lower airway inflammation in infants and young children with cystic fibrosis. Am J Respir Crit Care Med 156: 1197–1204
Armstrong D, Grimwood K, Carlin J, Carzino R, Olinsky A, Phelan P (1996) Bronchoalveolar lavage or oropharyngeal cultures to identify lower respiratory pathogens in infants with cystic fibrosis. Pediatr Pulmonol 21:267–275
Armstrong D, Grimwood K, Carzin, R, Carlin B, Olinsky A (1995) Lower airway inflammation in infants and young children with cystic fibrosis. Br Med J 310:1571–1572
Balfour-Lynn I, Laverty A, Dinwiddie R (1996) Reduced Upper airway nitric oxide in cystic fibrosis. Arch Dis Child 75:319–322
Balough K, McCubbin M, Weinberger M, Smits W, Ahrens R, Fick R (1995) The relationship between infection and inflammation in the early stages of lung disease from cystic fibrosis. Pediatr Pulmonol 20:63–70
Birrer P, McElvaney N, Rüderberg A, Wirz Sommer C, Liechti-Gallati S, Kraemer R, Hubbard R, Crystal R (1994) Protease-Antiprotease imbalance in the lungs of children with cystic fibrosis. Am J Respir Crit Care Med 150: 207–213
Bonfield T, Panuska J, Konstan M, Hilliard K, Hilliard J, Ghnaim H, Berger M (1995) Inflammatory cytokines in cystic fibrosis lungs. Am J Respir Crit Care Med 152: 2111–2118
Brown M, Morgan W, Finley P, Scuderi P (1991) Circulating levels of tumor necrosis factor and interleukin-1 in cystic fibrosis. Pediatr Pulmonol 10:86–91
Bruce MC, Poncz L, Klinger J, Stern RC, Tomashefski JJ, Dearborn D (1985 a) Biochemical and pathological evidence for proteolytic destruction of lung connective tissue in cystic fibrosis. Am Rev Respir Dis 132:529–535
Bruce MC, Wedig E, Jentoft N, Martin RC, Cheng PW, Boat TF, Fanaroff AA (1985 b) Altered urinary excretion of elastin cross-links in premature infants who develop bronchopulmonary dysplasia. Am Rev Respir Dis 131:568–572
de Rose V, Oliva A, Messore B, Grosso B, Mollar C, Pozzi E (1998)Circulating adhesion molecules in cystic fibrosis. Am J Respir Crit Care Med 157:1234–1239
Dötsch J, Demirakca S, Terbrack HG, Hüls G, Rascher W, Kühl PG (1996) Airway nitric oxide in asthmatic children and patients with cystic fibrosis. Eur Respir J 9:2537–2540
Eichler I, Nilsson M, Rath R, Enander I, Venge P, Koller DY (1999)Human neutrophil lipocalin, a highly specific marker for acute exacerbation in cystic fibrosis. Eur Respir J 14:1145–1149
Glass S, Hayward C, Govan J (1988) Serum C-reactive protein in assessment of pulmonary exacerbations and anti-microbial therapy in cystic fibrosis. J Pediatr 113:76–79
Grasemann H, Michler E, Wallot M, Ratjen F (1997) Decreased concentration of exhaled nitric oxide (NO) in patients with cystic fibrosis. Pediatr Pulmonol 24:173–177
Ho L, Faccenda J, Innes J, Greening A (1999) Expired hygrogen peroxide in breath condensate of cystic fibrosis patients. Eur Respir J 13:103–106
Ho L, Innes J, Greening A (1998) Exhaled nitric oxide is not elevated in the inflammatory airways diseases of cystic fibrosis and bronchiectasis. Eur Respir j 12:1290–1294
Hubeau C, Lorenzato M, Dusser D, Hubert D, Couetil JP, Puchelle E, Gaillard D (1999) Quantitative analysis of inflammatory cells in lung tissue from csystic fibrosis patients. Eur Respir J 14:18s–19s
Jaffar-Bandjee M, Lazdunski A, Bally M, Carrère J, Chazalette J, Galabert C (1995) Production of elastase, exotoxin A, and alkaline protease in Sputa during pulmonary exacerbation of cystic fibrosis in patients chronically infected by Pseudomonas aeruginosa. J Clin Microbiol 33: 924–929
Khan T, Wagener J, Bost T, Martinez J, Accurso F, Riches D (1995) Early pulmonary inflammation in infants with cystic fibrosis. Am J Respir Crit Care Med 151:1075–1082
Koller DY, Götz M, Wojnarowski C, Eichler I (1996) Relationship between disease severity and inflammatory markers in cystic fibrosis. Arch Dis Child 75:498–501
Koller DY, Nilsson M, Enander I, Venge P, Eichler I (1998) Serum eosinophil cationic protein, eosinophil protein X and eosinophil peroxidase in relation to pulmonary function in cystic fibrosis. Clin Exp Allergy 28:241–248
Koller D, Nething I, Otto J, Urbanek R, Eichler I (1997) Cytokine concentrations in Sputum from patients with cystic fibrosis and their relation to eosinophil activity. Am J Respir Crit Care Med 155:1050–1054
Konstan M, Hilliard K, Norvell T, Berger M (1994) Bronchoalveolar lavage findings in cystic fibrosis patients with stable, clinically mild lung disease suggest ongoing infection and inflammation. Am J Respir Crit Care Med 150: 448–454
Kronborg G, Hansen M, Svenson M, Foomsgaard A, Hoiby N, Bendtzen K (1993) Cytokines in Sputum and serum from patients with cystic fibrosis and chronic Pseudomonas infection as markers of destructiveinflammation in the lungs. Pediatr Pulmonol 15:292–297
Linnane S, Keatings V, Costello C, Moynihan J, O’Connor C, Fitzgerald M, McLoughlin P (1998) Total sputum nitrate plus nitrite is raised during acute pulmonary infection in cystic fibrosis. Am J Respir Crit Care Med 158:207–212
Lundberg JON, Nordvall SL, Weitzberg E, Kollberg H, Alving K (1996) Exhaled nitric oxide in paediatric asthma and cystic fibrosis. Arch Dis Child 75:323–326
Meyer K, Lewandowski J, Zimmerman J, Nunley D, Calhoun WJ, Dopico G (1991) Human neutrophil elastase and elastase/alphal-antiprotease complex in cystic fibrosis. Am Rev Respir Dis 144:580–585
Meyer K, Sharma A, Rosenthal N, Peterson K, Brennan L (1997) Regional variability of lung inflammation in cystic fibrosis. Am J Respir Crit Care Med 156:1536–1540
Nixon L, Yung B, Bell S, Elborn J, Shale D (1998) Circulation immunoreactive interleukin-6 in cystic fibrosis. Am J Respir Crit Care Med 157:1764–1769
Noah T, Black H, Cheng P-W, Wood R, Leigh M (1997) Nasal and bronchoalveolar lavage fluid cytokines in early cystic fibrosis. J Infect Dis 175:638–647
Norman D, Elborn J, Cordon S, Rayner R, Wiseman M, Hiller E, Shale D (1991) Plasma tumour necrosis factor alpha in cystic fibrosis. Thorax 46:91–95
Osika E, Cavaillon J-M, Chadelat K, Boule M, Fitting C, Tournier G, Clement A (1999) Distinc sputum cytokine profile in cystic fibrosis and other chronic inflammatory airway disease. Eur Respir J 14:339–346
Rayner R, Wiseman M, Cordon S, Norman D, Hiller E, Shale D (1991) Inflammatory markers in cystic fibrosis. Respir Med 85:139–145
Salva P, Doyle N, Graham L, Eigen H, Doerschuk C (1996) TNF-α, I1-8, soluble ICAM-1, and neutrophils in sputum of cystic fibrosis patients. Pediatr Pulmonol 21:11–19
Watkin S, Elborn J, Cordon S, Hiller E, Shale D (1994) C-reactive protein is not a useful indicator of intermittent bacterial colonization in early lung disease of patients with cystic fibrosis. Pediatr Pulmonol 17:6–10
Wilmott R, Kassab J, Kilian P, Benjamin W, Douglas S, Wood R (1990) Increased levels of interleukin-1 in bronchoalveolar washings from children with bacterial pulmonary infections. Am Rev Respir Dis 142:365–368
Wolter JM, Rodwell RL, Bowler SD, McCormack JG (1999) Cytokines and inflammatory mediators do not indicate acute infection in cystic fibrosis. Clin Diagn Lab Immunol 6:260–265
Worlitzsch D, Herberth G, Ulrich M, Döring G (1998) Catalase, myeloperoxidase and hydrogen peroxide in cystic fibrosis. Eur Respir J 11:377–383
Liteatur zu 5.9
Barbero G (1995) The undoing of a diagnosis: the effect of a misdiagnosis of a disease. Arch Pediatr Adolesc Med 149: 1341–1344
Feldman K, Barbero G (1996) False diagnosis of cystic fibrosis. Arch Pediatr Adolesc Med 150:1106–1107
Hill CM (1998) Practical guidelines for cystic fibrosis care. Churchill Livingstone, Edinburgh
Hodson M, Beldon I, Power R, Duncan F, Bamber, Batten J (1983) Sweat tests to diagnose cystic fibrosis in adults. Br Med J 286:1381–1383
Orenstein D, Wasserman A (1986) Munchhausen syndrome by proxy simulating cystic fibrosis. Pediatrics 78:621–624
Rosenstein BJ, Cutting G (1998) The diagnosis of cystic fibrosis: a consensus statement. J Pediatr 132:589–595
Wallis C (1997) Diagnosing cystic fibrosis: blood, sweat, and tears. Arch Dis Child 76:85–91
Wilson DC, Ellis L, Zielenski J, Corey M, Wan F, Tsui L-C, Tullis E, Knowles M, Durie P (1998) Uncertainty in the diagnosis of cystic fibrosis: possible role of in vivo nasal potential difference measurements. J Pediatr 132:596–599
Liteatur zu 5.10
Bhalla M, Turcios N, Aponte V, Jenkins M, Leitman BS, McCauley DI, Naidich DP (1991) Cystic fibrosis: scoring system with thin-section CT. Radiology 179:783–788
Brasfield D, Hicks G, Soong S, Peters J, Tiller R (1980) Evaluation of scoring system of the chest radiograph in cystic fibrosis: a collaborative study. Am J Roentgenol 134: 1195–1198
Brasfield D, Hicks G, Soong S, Tiller RE (1979) The chest roentgenogram in cystic fibrosis: a new scoring system. Pediatrics 63:24–29
Chrispin AR, Norman AP (1974) The systematic evaluation of the chest radiograph in cystic fibrosis. Pediatr Radiol 2: 101–105
Conway SP, Pond MN, Bowler I (1994) The chest radiograph in cystic fibrosis: a new scoring system compared with the Chrispin-Norman and Brasfield scores. Thorax 49:860–862
Corey M, McLaughlin FJ, Williams M, Levison H (1988) A comparison of survival, growth and pulmonary function in patients with cystic fibrosis in Boston and Toronto. J Clin Epidemiol 41:583–591
Doershuk CF, Matthews LW, Tucker AS, et al, Crystal RG (1964) A five year clinical evaluation of a therapeutic program for patients with cystic fibrosis. J Pediatr 65:677–693
Kraemer R, Birrer P, Liechti-Gallati S (1998) Genotype-phenotype association in infants with cystic fibrosis at the time of diagnosis. Pediatr Res 44:920–926
Kraemer R, Rüdeberg A, Hadorn B, Rossi E (1978) Relative underweight in cystic fibrosis and its prognostic value. Acta Paediatr Scand 67:33–37
Kraemer R, Rüdeberg A, Klay M, Rossi E (1979) Relationship between clinical conditions, radiographic findings and pulmonary functions in patients with cystic fibrosis. Helv Paediatr Acta 34:417–428
Kraemer R, Schöni MH (1990) Ventilatory inequalities, pulmonary function and blood oxygenation in advanced states of cystic fibrosis. Respiration 57:318–324
Kraemer R, Tschäppeler H, Rüdeberg A, Stoll E, Rossi E (1979) Verlauf und quantitative Erfassung des pulmonalen Befalls bei zystischer Fibrose. Schweiz Med Wochenschr 109:39–45
Lewiston N, Moss R, Hindi R, Rubinstein S, Sullivan M (1987) Interobserver variance in clinical scoring for cystic fibrosis. Chest 91:878–882
Liechti-Gallati S, Bonsall I, Malik N, Schneider V, Kraemer LG, Rüdeberg A, Moser H, Kraemer R (1992) Genotype/ phenotype association in cystic fibrosis: analyses of the delta F508, R553X, and 3905insT mutations. Pediatr Res 32: 175–178
Liechti-Gallati S, Schneider V, Neeser D, Kraemer R (1999) Two buffer PAGE system-based SSCP/HD analysis: a general protocol for rapid and sensitive mutation screening in cystic fibrosis and any other human genetic disease. Eur J Hum Genet 7:590–598
Nathanson I, Conboy K, Murphy S, Afshani E, Kuhn JP (1991) Ultrafast computerized tomography of the chest in cystic fibrosis: a new scoring system. Pediatr Pulmonol 11: 81–86
Sawyer SM, Carlin JB, DeCampo M, Bowes G (1994) Critical evaluation of three chest radiograph scores in cystic fibrosis (see comments). Thorax 49:863–866
Shwachman H, Kulczycki LL (1958) Long-term study of one hundred and five patients with cystic fibrosis: studies made over a five to fourtenn year period. Am J Dis Child 96:6–15
Stiglbauer R, Schurawitzki H, Eichler I, Götz M (1992) High-resolution CT in children with cystic fibrosis. Acta Radiologica 33:548–553
Taussig LM (1994) The score is… (editorial). Pediatr Pulmonol 17:279–280
Taussig LM, Kattwinkel J, Friedewald WT, di Sant Agnese PA (1973) A new prognostic score and clinical evaluation system for cystic fibrosis. J Pediatr 82:380–390
Weatherly MR, Palmer CG, Peters ME, Green CG, Fryback D, Langhough R, Farrell PM (1993) Wisconsin cystic fibrosis chest radiograph scoring system. Pediatrics 91: 488–495
Weatherly MR, Palmer CGS, Peter E et al. (1993) Wisconsin cystic fibrosis chest radiograph scoring system. Pediatrics 91:488–495
Wielinski CL, Warwick WJ, Budd JR (1990) Mortality and progression of the NIH clinical and prognostic score (abstract). Pediatr Pulmonol Suppl 5:259–260
Liteatur zu 5.11
Davis PB, Drumm M, Konstan MW (1996) Cystic fibrosis. State of the art. Am J Respir Crit Care Med 145:1229–1256
Ruzal-Shapiro C (1998) Cystic fibrosis: an overview. Radiol Clin North Am 36:143–161
MacLusky IB, Levison H (1992) Recent advances in cystic fibrosis. Curr Opin Pediatr 4:392–400
Katz JN, Horwitz RI, Dolan TF, Shapiro ED (1986) Clinical features as predictors of functional status in children with cystic fibrosis. J Pediatr 108:352–358
Dankert-Roelse JE, te Meerman GL (1995) Long term prognosis of patients with cystic fibrosis in relation to early detection by neonatal screening and treatment in a cystic fibrosis center. Thorax 50:712–718
Gibson LE, Cooke RE (1959) A test for concentration of electrolytes in sweat in cystic fibrosis of the pancreas utilizing pilocarpine by iontophoresis. Pediatrics 23:545–549
Ballabio A, Gibbs RA, Caskey CT (1990) Polymerase chain reaction test for cystic fibrosis detection. Nature 243: 220–225
Wood BP (1997) Cystic fibrosis: Radiology 1997 204:1–10
Shwachman H, Kulczycki LL (1958) Long term study of 105 patients with cystic fibrosis. Am J Dis Child 96:6–10
Chrispin AR, Norman AP (1974) The systematic evaluation of the chest radiograph in cystic fibrosis. Pediatr Radiol 2: 101–106
Brasfield D, Hicks G, Soong SJ, Peters J, Tiller R (1980) Evaluation of scoring system of the chest radiography in cystic fibrosis: a collaborative study. AJR 134:1195–1198
Cleveland RH, Neish AS, Zurakowski D, Nichols DP, Wohl MEB, Colin AA (1998) Cystic fibrosis: a system for assessing and predicting progress. AJR 170:1067–1072
Rosenberg SM, Howatt MF, Grum CM (1992) Spirometry and chest roentgenographic appearance in adults with cystic fibrosis. Chest 101:961–964
Grum CM, Lynch JP (1993) Chest radiograph findings in cystic fibrosis. Semin Respir Infect 7:193–209
Friedman PJ (1987) Chest radiograph findings in the adults with cystic fibrosis. Semin Roentgenol 22: 114–124
Amodio JB, Berdon WE, Abramson S, Baker D (1987) Cystic fibrosis in childhood: pulmonary, paranasal sinus, and skeletal manifestations. Semin Roentgenol 22:125–135
Bhalla M, Turcios N, Aponte V et al. (1991) Cystic fibrosis: scoring system with thin-section CT. Radiology 179: 783–788
Hansell DM, Strickland B (1989) High-resolution computed tomography in pulmonary cystic fibrosis. Br J Radiol 62:1–5
Helbich T, Stigelbauer R, Breitenseher M, Eichler I, Götz M, Schurawitzki H (1993) High-resolution computed tomography of the lung in young patients with cystic fibrosis. Radiologe 33:142–146
Maffessanti M, Candussi M, Brizzi F, Piovesana F (1996) Cystic fibrosis in children: HRCT findings and distribution of disease. J Thorac Imaging 11:27–38
Shah RM, Sexauer W, Ostrum BJ, Fiel S, Friedman A (1997) High-resolution CT in the acute exacerbation of cystic fibrosis: evaluation of acute findings, reversibility of those findings, and clinical correlation. AJR 169:375–380
Helbich TH, Heinz-Peer G, Fleischmann D et al. (1999) Evolution of CT findings in patients with cystic fibrosis. AJR 173:81–88
Helbich TH, Heinz-Peer G, Eichler I et al. (1999) Cystic fibrosis: assessment of lung involvement in children and adults. Radiology 213:537–544
Mostbeck GH, Caputo GR, Higgins CB (1992) MR measurement of blood flow in the cardiovascular system. AJR 159:453–61
Kinsella D, Hamilton A, Goddard P, Duncan A, Carswell F (1991) The role of magnetic resonance imaging in cystic fibrosis. Clin Radiol 44:23–26
Kauczor HU, Ebert M, Kreitner KF et al. (1997) Imaging of the lungs using 3He MRI: preliminary clinical experience in 18 patients with and without lung disease. JMRI 7: 538–543
Agrons GA, Corse WR, Markowitz RI, Stuarez ES, Perry DR (1996) Gastrointestinal manifestations of cystic fibrosis: radiologic-pathologic correlation. Radiographics 16: 871–893
Estroff JA, Parad RB, Benacerraf BR (1992) Prevalence of cystic fibrosis in fetuses with dilated bowel. Radiology 183: 677–680
Abramson S, Baker D, Amodio JB, Berdon WE (1987) Gastrointestinal manifestations of cystic fibrosis. Semin Roentgenol 22:97–113
Leonidas JC, Berdon WE, Baker DH, Santulli TV (1970) Meconium ileus and its complications. A reappraisal of piain film roentgen diagnostic criteria. AJR 108:598–609
Hen J, Dolan TF, Touloukian RJ (1980) Meconium plug syndrome associated with cystic fibrosis and Hirsch-sprung’s disease. Pediatrics 66:466–468
Bisset GS, Kirks DR (1988) Intussusception in infants and children: diagnosis and therapy. Radiology 168:141–145
Zerin JM, Kuhn-Fulton J, White SJ et al. (1995) Colonic strictures in children with cystic fibrosis. Radiology 194: 223–226
Schober E, Turetschek K, Schima W, et al. (1997) Methylcellulose enteroelysis spiral-CT: technique, examination quality and complications-experiences in 110 patients. Eur Radiol Suppl 7:118
Hernanz-Schulman M, Kirkpatrick J, Shwachman H, Herman T, Schulman G, Vawter GF (1986) Pneumatosis intestinalis in cystic fibrosis. Radiology 160:497–499
Wilschanski M, Fisher D, Hadas-Halperin I et al. (1999) Findings on routine abdominal ultrasonography in cystic fibrosis patients. J Pediatr Gastroenterol Nutr 28:182–185
Soyer P, Spelle L, Pelage JP et al. (1999) Cystic fibrosis in adolescentes and adults: fatty replacement of the pancreas — CT evaluation and functional correlation. Radiology 210: 611–615
Tham RT, Heyerman HG, Falke TH, et al. (1991) Cystic fibrosis: MR imaging of the pancreas. Radiology 179: 183–186
Hernanz-Schulman M, Teele RL, Perez-Atayde A et al. (1986) Pancreatic cystosis in cystic fibrosis. Radiology 158: 629–631
Patriquin H, Lenaerts C, Smith L, et al. (1999) Liver disease in children with in cystic fibrosis: US-biochemical comparison in 195 patients. Radiology 211:229–232
Quillin SP, Siegel MJ, Rothbaum R (1993) Hepatobiliary sonography in cystic fibrosis. Pediatr Radiol 23:533–535
Vergesslich KA, Götz M, Mostbeck G, Sommer G, Ponhold W (1989) Portal venous blood flow in cystic fibrosis: assessment by Duplex Doppler sonography. Pediatr Radiol 19:371–374
Helbich T, Breitenseher M, Heinz-Peer G et al. (1994) Color Doppler ultrasound of gallbladder varicose veins in children. A rare sign in portal hypertension. Ultraschall Med 15:126–130
Durieu I, Pellet O, Simonot L et al. (1999) Sclerosing cholangitis in adults with cystic fibrosis: a magnetic resonance cholangiographic prospective study. J Hepatol 30: 1052–1056
Eggesbo HB, Ringertz S, Haanäs OC et al. (1999) CT and MR imaging of the paranasal sinuses in cystic fibrosis: correlation with microbiological and histopathological results. Acta Radiol 40:154–162
Bedrossian CW, Greenberg SD, Singer DB, Hansen JJ, Rosenberg HS (1976) The lung in cystic fibrosis: a quantitative study including prevalence of pathologic findings among different age groups. Hum Pathol 7:195–204
Mayo JR, Hartman TE, Lee KS, Primack SL, Vedal S, Müller NL (1995) CT of the chest: minimal tube current for good image quality with the least radiation dose. AJR 164: 603–607
Holsclaw DS, Rocmans C, Shwachman H (1971) Intussusception in patients with cystic fibrosis. Pediatrics 48: 51–58
Borowitz DS, Grand RJ, Durie PR (1995) Use of pancreatic enzyme supplements for patients with cystic fibrosis in the context of fibrosing colonopathy. J Pediatr 127:681–684
Smyth RL, van-Velzen D, Smyth AR, Lloyd DA, Heaf DP (1994) Strictures of ascending colon in cystic fibrosis and high-strenght pancreatic enzymes. Lancet 343: 85–86
Thomas D, Rothberg RM, Lester LA (1985) Cystic fibrosis and gastroesophageal reflux in infancy. Am J Dis Child 139:66–67
Bending DW, Seilheimer DK, Wagner ML, Ferry GD, Barrison GM (1982) Complications of gastroesophageal reflux in patients with cystic fibrosis. J Pediatr 100:536–540
Williams SGJ, Evanson JE, Barrett N, Hodson ME, Boultbee JE, Westaby B (1995) An ultrasound scoring system for the diagnosis of liver disease in cystic fibrosis. J Hepatol 22: 513–521
Neglia JP, FitzSimmons SC, Maisonneuve P et al. (1995) The risk of cancer among patients with cystic fibrosis. N Engl J Med 1995 332:494–499
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Eichler, I. et al. (2001). Diagnostik der cystischen Fibrose. In: Reinhardt, D., Götz, M., Kraemer, R., Schöni, M.H. (eds) Cystische Fibrose. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-56796-4_5
Download citation
DOI: https://doi.org/10.1007/978-3-642-56796-4_5
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-63172-6
Online ISBN: 978-3-642-56796-4
eBook Packages: Springer Book Archive